Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
21.80
+0.09 (0.41%)
Dec 20, 2024, 4:00 PM EST - Market closed
IART Revenue
Integra LifeSciences Holdings had revenue of $380.83M in the quarter ending September 30, 2024, a decrease of -0.41%. This brings the company's revenue in the last twelve months to $1.56B, up 1.45% year-over-year. In the year 2023, Integra LifeSciences Holdings had annual revenue of $1.54B, down -1.03%.
Revenue (ttm)
$1.56B
Revenue Growth
+1.45%
P/S Ratio
1.08
Revenue / Employee
$396,584
Employees
3,946
Market Cap
1.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
Dec 31, 2019 | 1.52B | 45.12M | 3.06% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fortrea Holdings | 2.98B |
Teladoc Health | 2.59B |
Clover Health Investments | 2.12B |
10x Genomics | 629.74M |
Certara | 372.80M |
Dynavax Technologies | 260.81M |
Arcutis Biotherapeutics | 138.71M |
Xencor | 85.16M |
IART News
- 5 weeks ago - Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - GlobeNewsWire
- 6 weeks ago - Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Integra LifeSciences Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer - GlobeNewsWire
- 2 months ago - Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 - GlobeNewsWire
- 3 months ago - Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm - Business Wire
- 3 months ago - Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference - GlobeNewsWire
- 3 months ago - Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference - GlobeNewsWire